MRManon Ragonnet-Cronin

Manon Ragonnet-Cronin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manon Ragonnet-Cronin has a total of 456 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Representativeness of Regional Influenza Virus Genomic Surveillance for National Trends in the United States

    by Manon Ragonnet-Cronin, Leigh Papalambros, Emily E. Bendall, William J. Fitzsimmons, Christopher N. Blair, Robert Tibbetts, Ashish Bhargava, Adam Lauring

    Genomic surveillance of influenza viruses informs vaccine strain selection and evolutionary forecasting. Sequencing efforts vary widely across U.S. states, which raises concerns about spatial sampling bias. We evaluated how well 10,958 influenza virus genomes sampled by our group in Michigan captured the genetic diversity in 34,743 genomes circulating nationally from the 2021/22 through 2024/25 seasons. We defined seasonal hemagglutinin haplotypes and tracked their detection across states. A small number of haplotypes dominated each season, and Michigan detected all major haplotypes, even under substantial downsampling. Detection delays were primarily driven by haplotype frequency rather than geographic factors. Comparisons across states showed that higher sequencing effort improved coverage and detection timeliness, with diminishing returns at higher volumes. Rarefaction analysis confirmed that relatively few sequences were needed to capture 95% of national haplotype diversity. These findings suggest that intensive sequencing in a single well-sampled location can be broadly representative of national influenza diversity. One sentence summary: Dense influenza genomic sequencing from a single U.S. state captured nearly all nationally circulating haplotype diversity, with detection timeliness primarily driven by sequencing effort and haplotype frequency.

  • Open Access

    Phylodynamic Structure in the Botswana HIV Epidemic

    by Kenanao Kotokwe, Fabrícia F. Nascimento, Sikhulile Moyo, Simani Gaseitsiwe, Molly Pretorius Holme, Joseph Makhema, Max Essex, Vlad Novitsky, Erik Volz, Manon Ragonnet-Cronin, et al.

    Background Studying viral sequences can provide insights into the structure of host contact networks through which the virus is transmitted. Uncovering the population structure of the HIV-1 epidemic in Botswana will help optimise public health interventions and may identify hidden sub-epidemics. We sought to determine the phylodynamic structure of the Botswana HIV-1 epidemic from viral sequence genetic data. Methods The Botswana Combination Prevention Project (BCPP) randomly sampled 20% of households in 30 villages in Botswana between 2013–2018 and tested for HIV-1. Extensive demographic data were collected from all participants and next-generation full-genome HIV-1 sequences were generated from HIV-1 positive participants (n = 4,164), 78% of whom were on antiretroviral treatment (ART). We inferred the stage of infection (< or > 1 year) among HIV-1 cases based on nucleotide diversity and clinical data using a previously trained machine learning model. We then reconstructed time-resolved gag and pol phylogenies from sequences, other Botswana cohorts and publicly available sequences that were genetically close to those from Botswana. We statistically explored phylogenies for partitions with diverging patterns of coalescence, indicating sub-epidemics, and estimated viral effective population size through time, a measure of viral incidence, for each partition. Finally, we compared the demographic makeup, clinical and geographic characteristics across partitions using χ2, ANOVA tests and Tukey analysis. Results We identified three partitions of time-resolved gag and pol phylogenies, revealing divergent patterns of coalescence and HIV-1 transmission. In both gag and pol phylogenies, partitions with persistent growth and transmission were characterised by lower treatment coverage and more recent infections when compared to other partitions. The Southern and South East regions of Botswana were over-represented in the fast-growing partitions. Conclusion Our findings suggest that transmission is slowing in segments of the population that have high ART coverage. However, recent infections are over-represented in ongoing sub-epidemics. The phylodynamic structure suggests that there are districts with higher growth and prioritising these in the deployment of public health interventions might curb new infections. Nonetheless the high mobility of Botswana residents should be taken into consideration in implementing effective interventions to combat HIV-1.

  • Open Access

    Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy

    by Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, Aiste Dijokaite-Guraliuc, Raksha Das, Aekkachai Tuekprakhon, Piyada Supasa, Chang Liu, Muneeswaran Selvaraj, Natalie Groves, et al.

    COVID-19 patients at risk of severe disease may be treated with neutralising monoclonal antibodies (mAbs). To minimise virus escape from neutralisation these are administered as combinations e.g. casirivimab+imdevimab or, for antibodies targeting relatively conserved regions, individually e.g. sotrovimab. Unprecedented genomic surveillance of SARS-CoV-2 in the UK has enabled a genome-first approach to detect emerging drug resistance in Delta and Omicron cases treated with casirivimab+imdevimab and sotrovimab respectively. Mutations occur within the antibody epitopes and for casirivimab+imdevimab multiple mutations are present on contiguous raw reads, simultaneously affecting both components. Using surface plasmon resonance and pseudoviral neutralisation assays we demonstrate these mutations reduce or completely abrogate antibody affinity and neutralising activity, suggesting they are driven by immune evasion. In addition, we show that some mutations also reduce the neutralising activity of vaccine-induced serum.


  • Open Access

    Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana

    by Kenanao Kotokwe, Sikhulile Moyo, Melissa Zahralban-Steele, Molly Pretorius Holme, Pinkie Melamu, Catherine Kegakilwe Koofhethile, Wonderful Tatenda Choga, Terence Mohammed, Tapiwa Nkhisang, Baitshepi Mokaleng, et al.

    It remains unknown whether the C-C motif chemokine receptor type 5 (CCR5) coreceptor is still the predominant coreceptor used by Human Immunodeficiency Virus-1 (HIV-1) in Botswana, where the HIV-1 subtype C predominates. We sought to determine HIV-1C tropism in Botswana using genotypic tools, taking into account the effect of antiretroviral treatment (ART) and virologic suppression. HIV-1 gp120 V3 loop sequences from 5602 participants were analyzed for viral tropism using three coreceptor use predicting algorithms/tools: Geno2pheno, HIV-1C Web Position-Specific Score Matrices (WebPSSM) and the 11/25 charge rule. We then compared the demographic and clinical characteristics of people living with HIV (PLWH) harboring R5- versus X4-tropic viruses using χ2 and Wilcoxon rank sum tests for categorical and continuous data analysis, respectively. The three tools congruently predicted 64% of viruses as either R5-tropic or X4-tropic. Geno2pheno and the 11/25 charge rule had the highest concordance at 89%. We observed a significant difference in ART status between participants harboring X4- versus R5-tropic viruses. X4-tropic viruses were more frequent among PLWH receiving ART (χ2 test, p = 0.03). CCR5 is the predominant coreceptor used by HIV-1C strains circulating in Botswana, underlining the strong potential for CCR5 inhibitor use, even in PLWH with drug resistance. We suggest that the tools for coreceptor prediction should be used in combination.


  • Open Access

    Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana

    by Lynnette Bhebhe, Sikhulile Moyo, Simani Gaseitsiwe, Molly Pretorius-Holme, Etienne K. Yankinda, Kutlo Manyake, Coulson Kgathi, Mompati Mmalane, Refeletswe Lebelonyane, Tendani Gaolathe, et al.

    Background: HIV-1 is endemic in Botswana. The country’s primary challenge is identifying people living with HIV who are unaware of their status. We evaluated factors associated with undiagnosed HIV infection using HIV-1 phylogenetic, behavioural, and demographic data. Methods: As part of the Botswana Combination Prevention Project, 20% of households in 30 villages were tested for HIV and followed from 2013 to 2018. A total of 12,610 participants were enrolled, 3596 tested HIV-positive at enrolment, and 147 participants acquired HIV during the trial. Extensive socio-demographic and behavioural data were collected from participants and next-generation sequences were generated for HIV-positive cases. We compared three groups of participants: (1) those previously known to be HIV-positive at enrolment (n = 2995); (2) those newly diagnosed at enrolment (n = 601) and (3) those who tested HIV-negative at enrolment but tested HIV-positive during follow-up (n = 147). We searched for differences in demographic and behavioural factors between known and newly diagnosed group using logistic regression. We also compared the topology of each group in HIV-1 phylogenies and used a genetic diversity-based algorithm to classify infections as recent (< 1 year) or chronic (≥ 1 year). Results: Being male (aOR = 2.23) and younger than 35 years old (aOR = 8.08) was associated with undiagnosed HIV infection (p < 0.001), as was inconsistent condom use (aOR = 1.76). Women were more likely to have undiagnosed infections if they were married, educated, and tested frequently. For men, being divorced increased their risk. The genetic diversity-based algorithm classified most incident infections as recent (75.0%), but almost none of known infections (2.0%). The estimated proportion of recent infections among new diagnoses was 37.0% (p < 0.001). Conclusion: Our results indicate that those with undiagnosed infections are likely to be young men and women who do not use condoms consistently. Among women, several factors were predictive: being married, educated, and testing frequently increased risk. Men at risk were more difficult to delineate. A sizeable proportion of undiagnosed infections were recent based on a genetic diversity-based classifier. In the era of “test and treat all”, pre-exposure prophylaxis may be prioritized towards individuals who self-identify or who can be identified using these predictors in order to halt onward transmission in time.


  • Open Access

    Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2

    by Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, Aiste Dijokaite-Guraliuc, Raksha Das, Aekkachai Tuekprakhon, Piyada Supasa, Chang Liu, Muneeswaran Selvaraj, Natalie Groves, et al.

    Summary: Some COVID-19 patients are unable to clear their infection or are at risk of severe disease, requiring treatment with neutralising monoclonal antibodies (nmAb) and/or antivirals. The rapid roll-out of novel therapeutics means there is limited understanding of the likely genetic barrier to drug resistance. Unprecedented genomic surveillance of SARS-CoV-2 in the UK has enabled a genome-first approach to the detection of emerging drug resistance. Here we report the accrual of mutations in Delta and Omicron cases treated with casirivimab+imdevimab and sotrovimab respectively. Mutations occur within the epitopes of the respective nmAbs. For casirivimab+imdevimab these are present on contiguous raw reads, simultaneously affecting both components. Using surface plasmon resonance and pseudoviral neutralisation assays we demonstrate these mutations reduce or completely abrogate antibody affinity and neutralising activity, suggesting they are driven by immune evasion. In addition, we show that some mutations also reduce the neutralising activity of vaccine-induced serum.


  • Open Access

    Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana

    by Lynnette Bhebhe, Sikhulile Moyo, Simani Gaseitsiwe, Molly Pretorius-Holme, Etienne K. Yankinda, Kutlo Manyake, Coulson Kgathi, Mompati Mmalane, Refeletswe Lebelonyane, Tendani Gaolathe, et al.

    Background: HIV-1 is endemic in Botswana. The country’s primary challenge is identifying persons living with HIV who are unaware of their status. We evaluated factors associated with undiagnosed HIV infection using HIV-1 phylogenetic, behavioural, and demographic data. Methods: As part of the Botswana Combination Prevention Project, 20% of adults residing in 30 villages were tested for HIV and followed from 2013 to 2018. A total of 12,610 participants were enrolled, 3,596 tested HIV-positive at enrolment, and 147 participants acquired HIV during the trial. Extensive socio-demographic and behavioural data were collected from participants and next-generation sequences were generated for HIV-positive cases. We compared three groups of participants: 1) those previously known to be HIV-positive at enrolment (n=2,995); 2) those newly diagnosed at enrolment (n=601) and 3) those who tested HIV-negative at enrolment but tested HIV-positive during follow-up (n=147). We searched for differences in demographic and behavioural factors between known and newly diagnosed group using logistic regression. We also compared the topology of each group in HIV-1 phylogenies and used a genetic diversity-based algorithm to classify infections as recent (Results: Being male (aOR=2.23), younger than 35 years old (aOR=8.08), educated and married was associated with undiagnosed HIV infection (pppConclusion: Our results indicate that those with undiagnosed infections are likely to be younger, educated, married, men who do not consistently use condoms with their partners. Notably, these men have been tested for HIV previously, and a sizeable proportion had recent infections based on a genetic diversity-based classifier, suggesting that they are aware of their risk. In the era of “test and treat all”, these identified predictors may help better prioritize groups for prevention and testing.

  • Forecasting HIV-1 Genetic Cluster Growth in Illinois,United States

    by Manon Ragonnet-Cronin, Christina Msc Hayford, Richard D'AQuila, Fangchao Ma, Cheryl Msc Ward, Nanette Mas Benbow, Joel O. Wertheim

    Background: HIV intervention activities directed toward both those most likely to transmit and their HIV-negative partners have the potential to substantially disrupt HIV transmission. Using HIV sequence data to construct molecular transmission clusters can reveal individuals whose viruses are connected. The utility of various cluster prioritization schemes measuring cluster growth have been demonstrated using surveillance data in New York City and across the United States, by the Centers for Disease Control and Prevention (CDC). Methods: We examined clustering and cluster growth prioritization schemes using Illinois HIV sequence data that include cases from Chicago, a large urban center with high HIV prevalence, to compare their ability to predict future cluster growth. Results: We found that past cluster growth was a far better predictor of future cluster growth than cluster membership alone but found no substantive difference between the schemes used by CDC and the relative cluster growth scheme previously used in New York City (NYC). Focusing on individuals selected simultaneously by both the CDC and the NYC schemes did not provide additional improvements. Conclusion: Growth-based prioritization schemes can easily be automated in HIV surveillance tools and can be used by health departments to identify and respond to clusters where HIV transmission may be actively occurring.


  • Open Access

    Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana

    by Manon Ragonnet-Cronin, Tanya Golubchik, Sikhulile Moyo, Christophe Fraser, Max Essex, Vlad Novitsky, Erik Volz

    Human immunodeficiency virus (HIV)-1 genetic diversity increases during infection and can help infer the time elapsed since infection. However, the effect of antiretroviral treatment (ART) on the inference remains unknown. Participants with estimated duration of HIV-1 infection based on repeated testing were sourced from cohorts in Botswana (n = 1944). Full-length HIV genome sequencing was performed from proviral deoxyribonucleic acid. We optimized a machine learning model to classify infections as < or >1 year based on viral genetic diversity, demographic, and clinical data. The best predictive model included variables for genetic diversity of HIV-1 gag, pol, and env, viral load, age, sex, and ART status. Most participants were on ART. Balanced accuracy was 90.6% (95% confidence interval, 86.7%–94.1%). We tested the algorithm among newly diagnosed participants with or without documented negative HIV tests. Among those without records, those who self-reported a negative HIV test within 1 year previously. There was no difference in classification between those self-reporting a negative HIV test <1 year, whether or not they had a record. These results indicate that recency of HIV-1 infection can be inferred from viral sequence diversity even among patients on suppressive ART.


  • Open Access

    Interplay Between Geography and HIV Transmission Clusters in Los Angeles County

    by Britt Skaathun, Manon Ragonnet-Cronin, Kathleen Poortinga, Zhijuan Sheng, Yunyin W Hu, Joel O Wertheim

    Background: Clusters of HIV diagnoses in time and space and clusters of genetically linked cases can both serve as alerts for directing prevention and treatment activities. We assessed the interplay between geography and transmission across the Los Angeles County (LAC) HIV genetic transmission network. Methods: Deidentified surveillance data reported for 8186 people with HIV residing in LAC from 2010 through 2016 were used to construct a transmission network using HIV-TRACE. We explored geographic assortativity, the tendency for people to link within the same geographic region; concordant time–space pairs, the proportion of genetically linked pairs from the same geographic region and diagnosis year; and Jaccard coefficient, the overlap between geographical and genetic clusters. Results: Geography was assortative in the genetic transmission network but less so than either race/ethnicity or transmission risk. Only 18% of individuals were diagnosed in the same year and location as a genetically linked partner. Jaccard analysis revealed that cis-men and younger age at diagnosis had more overlap between genetic clusters and geography; the inverse association was observed for trans-women and Blacks/African Americans. Conclusions: Within an urban setting with endemic HIV, genetic clustering may serve as a better indicator than time–space clustering to understand HIV transmission patterns and guide public health action.